Offene Studien Hämatologie
Lymphome
-
- HD21 for advanced stages: Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 6 cy-cles of escalated BEACOPP with 6 cycles of BrECADD
- SAKK 38/19: Protocol SAKK 38/19 Assesing a ctDNA and PET-oriented therapy in patients with DLBCLA multicente, open-label, phase II trial.
- INCMOR 0208-301: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL ...
Leukämien
-
- Hovon 150: A phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib or enasidenib in combination with induction therapy and consolidation therapy followed by maintenancetherapy in patients with newly diagnosed acute ...
- CAR T-Cel: EBMT Registry data processing framework
- HOVEN 156: A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by o...
- SAKK CLL 17: Eine prospektive, randomisierte, unverblindete, multizent-rische Phase-III-Studie zum Vergleich der Wirksamkeit und Sicherheit von Ibrutinib Monotherapie ....